Transparency Market Research Report Added "Pulmonary Drug Delivery Systems Market" to its database.
Albany, NY -- (SBWIRE) -- 12/29/2015 -- Transparency Market Research announces the release of a new research report, titled "Pulmonary Drug Delivery Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019". According to the study, the global pulmonary drug delivery systems market is anticipated to grow from a value of US$21.0 bn in 2012 to US$28.7 bn in 2019, at a 4.50% CAGR during that period.
Browse the full Pulmonary Drug Delivery Systems Market (Products - Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers; Applications - Asthma, COPD and Cystic Fibrosis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at http://www.transparencymarketresearch.com/pulmonary-drug-delivery-systems.html
The primary factor propelling the pulmonary drug delivery systems market is the rising incidence of asthma, chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. According to the World Health Organization, in 2012, over 3 mn people died of COPD, amounting to 6.0% of all deaths that occurred around the globe that year. By 2030, this disease is estimated to become the third leading cause of death worldwide. WHO also states that an estimated 235 mn people presently suffer from asthma, the most common non-communicable disease among children. The U.S. Cystic Fibrosis Foundation reveals that an estimated 70,000 people worldwide and 30,000 people in the U.S. are living with cystic fibrosis. Each year, approximately 1,000 new cases of cystic fibrosis are diagnosed.
The pulmonary drug delivery systems market is segmented on the basis of product type into dry powder inhalers (DPIs), metered dose inhalers (MDIs) and nebulizers. On the basis of application, the market is categorized into COPD, asthma, and cystic fibrosis.
The global pulmonary drug delivery systems market is divided on the basis of geography into Asia Pacific, North America, Europe, and Rest of the World. In 2012, North America dominated the global market in terms of revenue, driven by a number of factors such as increased level of awareness regarding pulmonary drug delivery systems, well-established reimbursement scenario, and high prevalence of COPD and asthma.
Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=873
Even though Europe is presently the second largest pulmonary drug delivery systems market in the world, it is anticipated to lose market share over the coming years owing to government austerity measures to reduce prices in key markets and increased penetration by manufacturers of generic drugs and delivery systems. Asia Pacific, on the other hand, is likely to show the highest CAGR during the forecast period owing to rise in healthcare expenditure, increasing incidence of respiratory diseases resulting from alarming levels of air pollution and surge in tobacco consumers, and growing level of patient awareness.
The noteworthy players competing in the global pulmonary drug delivery systems market include GF Health Products Inc., GlaxoSmithKline plc, 3M Health Care, Omron Healthcare, Inc., AstraZeneca plc, Sunovion Pharmaceuticals Inc., CareFusion Corporation, Merck & Co., Allied Healthcare Products, Inc., Philips Respironics, Inc., Boehringer Ingelheim, PARI Respiratory Equipment, Inc., and Novartis AG. These players are profiled in the pulmonary drug delivery systems market report based on company and financial overview, business strategies, product portfolio, and recent developments.
Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/pulmonary-drug-delivery-systems-market.htm
Pulmonary Drug Delivery Systems Market, by Product Type
Metered Dose Inhalers (MDIs)
Dry Powder Inhalers (DPIs)
Pulmonary Drug Delivery Systems Market, by Application
Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Drug Delivery Systems Market, by Geography
Rest of the World (RoW)
About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr. Sudip S
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453